TY - JOUR
T1 - Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium
AU - Leung, Cleo
AU - Utokaparch, Soraya
AU - Sharma, Arpeeta
AU - Yu, Carol
AU - Abraham, Thomas
AU - Borchers, Christoph
AU - Bernatchez, Pascal
N1 - Funding Information:
This work was supported by grants from Canadian Institutes for Health Research (CIHR), Michael Smith Foundation for Health Research, Canadian Foundation for Innovation, British Columbia Protein Network and Providence Health Care Research Institute. We also thank D. Smith and D. Hardie for the help on proteomic analysis.
PY - 2011/11/18
Y1 - 2011/11/18
N2 - Dysferlin is a membrane-anchored protein known to facilitate membrane repair in skeletal muscles following mechanical injury. Mutations of dysferlin gene impair sarcolemma integrity, a hallmark of certain forms of muscular dystrophy in patients. Dysferlin contains seven calcium-dependent C2 binding domains, which are required to promote fusion of intracellular membrane vesicles. Emerging evidence reveal the unexpected expression of dysferlin in non-muscle, non-mechanically active tissues, such as endothelial cells, which cast doubts over the belief that ferlin proteins act exclusively as membrane repair proteins. We and others have shown that deficient trafficking of membrane bound proteins in dysferlin-deficient cells, suggesting that dysferlin might mediate trafficking of client proteins. Herein, we describe the intracellular trafficking and movement of GFP-dysferlin positive vesicles in unfixed reconstituted cells using live microscopy. By performing GST pull-down assays followed by mass spectrometry, we identified dysferlin binding protein complexes in human vascular endothelial cells. Together, our data further support the claims that dysferlin not only mediates membrane repair but also trafficking of client proteins, ultimately, help bridging dysferlinopathies to aberrant membrane signaling.
AB - Dysferlin is a membrane-anchored protein known to facilitate membrane repair in skeletal muscles following mechanical injury. Mutations of dysferlin gene impair sarcolemma integrity, a hallmark of certain forms of muscular dystrophy in patients. Dysferlin contains seven calcium-dependent C2 binding domains, which are required to promote fusion of intracellular membrane vesicles. Emerging evidence reveal the unexpected expression of dysferlin in non-muscle, non-mechanically active tissues, such as endothelial cells, which cast doubts over the belief that ferlin proteins act exclusively as membrane repair proteins. We and others have shown that deficient trafficking of membrane bound proteins in dysferlin-deficient cells, suggesting that dysferlin might mediate trafficking of client proteins. Herein, we describe the intracellular trafficking and movement of GFP-dysferlin positive vesicles in unfixed reconstituted cells using live microscopy. By performing GST pull-down assays followed by mass spectrometry, we identified dysferlin binding protein complexes in human vascular endothelial cells. Together, our data further support the claims that dysferlin not only mediates membrane repair but also trafficking of client proteins, ultimately, help bridging dysferlinopathies to aberrant membrane signaling.
UR - http://www.scopus.com/inward/record.url?scp=84855890343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855890343&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2011.10.031
DO - 10.1016/j.bbrc.2011.10.031
M3 - Article
C2 - 22037454
AN - SCOPUS:84855890343
SN - 0006-291X
VL - 415
SP - 263
EP - 269
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -